Showing results (481-490 of 941) with videos related to
Sort By:
Pageof 95
Neurology and Therapy|July 13, 2022
Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in GreeceEfthymios Dardiotis, Georgia Perpati, Mariann Borsos, et al.Neurology and Therapy|November 20, 2023
Podcast on Identifying and Understanding Barriers to Care in Underserved Populations With MS in the United StatesSandra Parawira, Victoria ReeseNeurology and Therapy|November 10, 2023
Paroxysmal Sympathetic Hyperactivity After Acquired Brain Injury: An Integrative Review of Diagnostic and Management ChallengesSui-Yi Xu, Qi Zhang, Chang-Xin LiNeurology and Therapy|September 12, 2023
Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled AnalysisShigekazu Kitamura, Takao Takeshima, Daishi Yui, et al.Neurology and Therapy|September 12, 2023
Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized TrialMamoru Shibata, Atsuko Nihira, Yuka Tanji, et al.Neurology and Therapy|September 8, 2023
Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS TreatmentAngelo Ghezzi, R F NeuteboomNeurology and Therapy|August 2, 2023
The Functional Prognosis of Rescue Conscious Sedation During Mechanical Thrombectomy on Patients with Acute Anterior Circulation Ischemic Stroke: A Single-Center Retrospective StudyShilin Li, Yu Zhang, Xiaobo Zhang, et al.Neurology and Therapy|August 26, 2023
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 StudyJason Aldred, Eric Freire-Alvarez, Alexander V Amelin, et al.Neurology and Therapy|October 4, 2023
Predicting of Mechanical Ventilation and Outcomes by Using Models and Biomarker in Guillain-Barré SyndromeJiajia Yao, Rumeng Zhou, Yue Liu, et al.Neurology and Therapy|October 4, 2023
Consensus-Based Recommendations on the Use of CGRP-Based Therapies for Migraine Prevention in the UAETaoufik Alsaadi, Deeb M Kayed, Abubaker Al-Madani, et al.Pageof 95